Abacavir monosulfate is used as a competitive, orally active nucleoside reverse transcriptase inhibitor for the inhibition of HIV replication; it exhibits anticancer activity in prostate cancer cell lines and can cross the blood-brain barrier to inhibit telomerase activity.